2009-03-30 07:30:00 CEST
2009-03-30 07:30:14 CEST
REGULATED INFORMATION
Biohit Oyj - Notice to general meeting
NOTICE OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ
BIOHIT OYJ STOCK EXCHANGE RELEASE 30 MARCH 2009 AT 08:30 AM NOTICE OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ Notice is given to the shareholders of Biohit Oyj to the Annual General Meeting (AGM) to be held on 20 April 2009 at 17:00 (5:00 pm) at Pörssisali, Fabianinkatu 14, 00100 Helsinki. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 16:00 (4:00 pm). A. Matters on the agenda of the Annual General Meeting At the AGM, the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order 3. Election of persons to scrutinize the minutes and to supervise the counting of votes 4. Recording the attendance at the meeting and adoption of the list of votes 5. Recording the legality of the meeting and presence of a quorum 6. Presentation of the financial statements, the report of the Board of Directors and the auditor's report for the financial year 2008, as well as the review by the CEO 7. Adoption of the financial statements 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the AGM that and that the profit for the financial year 2008 be transferred to the retained profit and loss account and that no dividends will be distributed. 9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability 10. Resolution on the number of members of the Board of Directors and their remuneration Shareholders representing over 50% of the votes associated with the Group's shares have issued notification that they are going to propose to the AGM that the number of members of the Board of Directors be six (6). In addition, the above-mentioned shareholders have issued notification that they are going to propose to the AGM that that the monthly fees payable to the members and the Chairman of the Board remain unchanged: EUR 1,550 for the Chairman of the Board, and EUR 1,200 for each Board member. 11. Election of members of the Board of Directors The above-mentioned shareholders have issued notification that they are going to propose to the AGM that the following members of the Board be re-elected: Kalle Kettunen, Reijo Luostarinen, Mikko Salaspuro and Osmo Suovaniemi. They are also proposing that Jukka Ant-Wuorinen and Eero Lehti be elected as new members of the Board. The members of Board are elected for the term of office continuing until the end of the next AGM. More information about the new candidates is available on the company's website at www.biohit.com/investors. 12. Resolution on the remuneration of the auditor The Board of Directors will propose that the auditor be remunerated in accordance with an invoice presented. 13. Election of the Auditor The above-mentioned shareholders have issued notification that they are going to propose that Ernst & Young Oy, Authorised Public Accountants, continue as the company's auditor for the term of office continuing until the end of the next AGM. 14. Closing of the meeting B. Documents of the Annual General Meeting The proposals of the Board of Directors relating to the agenda of the AGM as well as this notice are available on Biohit Oyj's website at www.biohit.com/investors. The financial statements of Biohit Oyj, including the report of the Board of Directors and the auditor's report, will be published on 31 March 2009 and will after that be available on the above-mentioned website, as well as at the company's headquarters at Laippatie 1, 00880 Helsinki. The proposals of the Board of Directors and the financial statements are also available at the meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the AGM will be available on the above-mentioned website no later than 24 April 2009. C. Instructions for those participating in the Annual General Meeting 1. The right to participate and registration Each shareholder who, on 9 April 2009, is registered in the shareholder register for the company maintained by Euroclear Finland Ltd (formerly Finnish Central Securities Depository Ltd) has the right to participate in the Annual General Meeting. All shareholders with shares registered in a personal book-entry account will be registered in the company's shareholder register. Shareholders who wish to participate in the AGM must register for the meeting no later than Thursday, 16 April 2009 at 12:00 (12:00 noon) by giving prior notice of this. Such notice can be given as of 1 April 2009 at 12:00 (12:00 noon): a) On the company's website at www.biohit.com/investors b) By email to yhtiokokous@biohit.com c) Per telephone +358-9-7738 61, or d) By regular mail to: Biohit Oyj, Yhtiökokous, Laippatie 1, 00880 Helsinki In connection with the registration, a shareholder shall notify his/her name, personal identification number, address, telephone number and the name of a possible assistant. The personal data given to Biohit Oyj is used only in connection with the general meeting and with the processing of related registrations. 2. Proxy representative and powers of attorney A shareholder may participate in the general meeting and exercise his/her rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the general meeting. Possible proxy documents should be delivered in originals to Biohit Oyj, Yhtiökokous, Laippatie 1, 00880 Helsinki. 3. Holders of nominee registered shares A holder of nominee registered shares, who wants to participate in the general meeting, must be entered into the shareholders' register of the company on the record date (9 April 2009) of the meeting. A holder of nominee registered shares is advised to request necessary instructions regarding the registration in the shareholder's register of the company, the issuing of proxy documents and registration for the general meeting from his/her custodian bank. Further information on these matters can also be found on the company's website at www.biohit.com/investors. 4. Other instructions and information On the date of this notice to the general meeting (30 March 2009), the total number of shares in Biohit Oyj is 12,937,627. Shares are divided into series A and series B shares. There are 2,975,500 series A shares and 9,962,127 series B shares. Series A shares confer twenty (20) votes at General Meetings and Series B shares confer one (1) vote. Helsinki on 30 March 2009 Biohit Oyj Board of Directors Further information: Osmo Suovaniemi, M.D., Ph.D., Professor President & CEO Tel: +358-9-773 861 GSM: +358-40-745 5605 Email: osmo.suovaniemi@biohit.com Distribution: NASDAQ OMX Helsinki Oy Central storage facility (www.oam.fi) Press www.biohit.com About Biohit Oyj Biohit Oyj develops, manufactures and markets liquid handling products and diagnostic test systems for use in research, health care and industrial laboratories. Liquid handling products include electronic and mechanical pipettes and dispensers, and disposable tips, as well as pipette maintenance and calibration services. Diagnostics business comprises products and analysis systems for diagnosing, screening and prevention of gastrointestinal diseases, e.g. the blood-sample based GastroPanel and GastroView, for diagnosing diseases of the stomach and associated risks, as well as quick tests for the diagnosis of lactose intolerance, H. pylori infection and fecal occult blood. Biohit Oyj is headquartered in Finland. Biohit has subsidiaries in France, Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit's products are sold by approximately 450 distributors in 70 countries. Biohit's share (BIOBV) is quoted on NASDAQ OMX Helsinki. Read more at www.biohit.com
© 2024 Nasdaq, Inc. All Rights Reserved |